CRISPR patent “case of the year” hearing is a must-watch – and not just for the life sciences
Reset password
Register to access two of our subscriber only articles per month.
Register
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
Subscribe
Author | Life sciences reporter
[email protected]
@IAM_magazine China's government weighs in on a low-profile US patent dispute, latest sign of geopolitical IP tensions https://t.co/ghCyBkxARb Read more
@IAM_magazine In its big-ticket licensing fight with Ericsson, Samsung has filed its first challenges at the PTAB but its move sh… https://t.co/6EMSSfyDgh Read more
@IAM_magazine Allergan’s Botox trade secrets win at the ITC win underlines the commission's growing importance in life sciences I… https://t.co/1zjhfn9Ebf Read more
@IAM_magazine Once a rising supply chain star and a big patent buyer, now a Chinese company that landed on the Entity List is mov… https://t.co/qDQbTl4jnr Read more
